Land: Taiwan
Sprache: Chinesisch
Quelle: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
FOLLITROPIN ALFA(r-hFSH)
台灣默克股份有限公司 台北市內湖區堤頂大道2段89號6樓 (23526610)
G03GA05
注射劑
FOLLITROPIN ALFA(r-hFSH) (6818000500) MCG
注射匣;;注射器;;盒裝
菌 疫
限由醫師使用
MERCK SERONO S.P.A. VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALY IT
follitropin alfa
女性患者(1)婦女經CLOMIPHENE CITRATE治療,仍無法排卵者(含多囊性卵巢症,PCOD) 。(2)對於實施人工生殖協助技術(ART),如體外受精(IVF),配子輸卵管植入(GIFT),合子輸卵管植入(ZIFT)的病人,可刺激其多濾泡發育。(3)與黃體刺激素(LH)併用,使用於嚴重缺乏黃體刺激激素與濾泡刺激激素患者的濾泡刺激成長。男性患者治療男性對於患有先天或後天性腺刺激素不足之性腺功能低下症,併用人類絨毛膜性腺刺激素(hCG),刺激精子生成。
有效日期: 2025/05/04; 英文品名: GONAL-F 300IU/0.5ML solution for injection in pre-filled pen
2005-05-04
300 IU SOLUTION FOR INJECTION IN PRE-FILLED PEN 450 IU SOLUTION FOR INJECTION IN PRE-FILLED PEN 900 IU SOLUTION FOR INJECTION IN PRE-FILLED PEN INGREDIENT: Active ingredient: follitropin alfa Follitropin alfa is recombinant human follicle stimulating hormone (r-hFSH) produced in Chinese Hamster Ovary cells by recombinant DNA technology. COMPOSITION _GONAL-f 300 IU_ _solution for injection in pre-filled _ _pen: _ Each ml of the solution contains 600 IU (International Units) of follitropin alfa, (equivalent to 44 micrograms). Each pre-filled multidose pen delivers 300 IU (equivalent to 22 micrograms) in 0.5 ml. _GONAL-f 450 IU solution for injection in pre-filled _ _pen: _ Each ml of the solution contains 600 IU (International Units) of follitropin alfa, (equivalent to 44 micrograms). Each pre-filled multidose pen delivers 450 IU (equivalent to 33 micrograms) in 0.75 ml. _GONAL-f 900 IU solution for injection in pre-filled _ _pen: _ Each ml of the solution contains 600 IU (International Units) of follitropin alfa, (equivalent to 44 micrograms). Each pre-filled multidose pen delivers 900 IU (equivalent to 66 micrograms) in 1.5 ml. CLINICAL PROPERTIES INDICATIONS Women Anovulation including polycystic ovarian syndrome in women who have been unresponsive to treatment with clomiphene citrate. Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as _in vitro_ fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra-fallopian transfer (ZIFT). GONAL-f in association with a luteinising hormone (LH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/l. Men Stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human Chorionic Gonadotropin (hCG) therapy. DOSAGE AND ADMINISTRATION Treatment with GONAL-f should be initia Lesen Sie das vollständige Dokument